Atlas Trials

Study Assessing Safety and Efficiency of the Lenalidomide and Dexamethasone Combination in Patients With Chronic Lymphatic Leukemia (CLL) Relapsing or Resistant to Treatment

Clinical trial NCT01246557 · COMPLETED

Trial details

NCT number
NCT01246557
Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Chronic Lymphatic Leukemia
Start date
2009-12-01
Primary completion
2014-04-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.